Co-Administration of HIV Env Protein with DNA and/or NYVAC Vaccines in Humans Results in Earlier and Potent Generation of Anti-Env Antibody Responses
Year: 2019
Type: preprint
Study designs: Randomized Controlled Trial, Clinical Trial
Source: SSRN Electronic Journal
DOI: 10.2139/ssrn.3324748
Authors: Giuseppe Pantaleo, Holly Janes, Shelly Karuna, Shannon Grant, Laissa Ouedraogo, Mary Allen, Georgia D. Tomaras, Nicole Frahm, David C. Montefiori, Guido Ferrari, Song Ding, Carter Lee, Merlin L. Robb, Mariano Esteban, Ralf Wagner, Pierre Alexandre-Bart, Nils Rettby, M. Juliana McElrath, Peter B. Gilbert, James Kublin, Lawrence Corey, NIAID HIV Vaccine Trials Network
Institutions: Swiss Vaccine Research Institute, University of Lausanne, Fred Hutch Cancer Center, Government of the United States of America, National Institute of Allergy and Infectious Diseases, Duke Medical Center, Duke University, Eurovacc Foundation, Global Solutions for Infectious Diseases, Walter Reed Army Institute of Research, Consejo Superior de Investigaciones Científicas, University of Regensburg
Language: English
Topic: HIV Research and Treatment
Subfield: Virology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: green
OpenAlex ID: W3160898415